A New Era in Neuro-Oncology

At the forefront of brain and spine tumor treatment, the Allegheny Health Network (AHN) is reshaping patient care through a comprehensive and personalized strategy that combines innovative therapies and a collaborative medical team.

AHN’s multidisciplinary unit, comprised of neuro-oncologists, neurosurgeons, medical oncologists, radiation oncologists, and radiologists, works harmoniously to craft individualized care plans that align with each patient’s unique condition and goals. Essential to this cohesive care experience are AHN's dedicated nurse navigators, who provide tailored support, streamline communication, and serve as passionate advocates for patients and their families.

Leading the Charge in Advanced Tumor Therapies

Renowned as a pioneer in medical innovation, AHN’s facilities offer cutting-edge treatments for both benign and malignant tumors—especially in complex cases where traditional methods have fallen short.

Introducing GammaTile Brachytherapy

Among the first in Pennsylvania to implement GammaTile brachytherapy, AHN’s neurosurgeons are breaking ground with this groundbreaking approach. This innovative method involves surgically embedding Cesium-131 radiation seeds within the resection cavity immediately after tumor removal. This technique not only effectively targets residual tumor cells but also protects healthy brain tissue.

Dr. Matthew Shepard, a neurosurgeon at AHN, emphasizes the significance of this method: "By integrating GammaTile during surgery, we provide immediate adjuvant therapy, making it accessible even to patients unable to attend follow-up sessions. Early results show promise in reducing local recurrence and improving overall survival rates."